comparemela.com

India Exclusive News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ayushmann Khurrana Is The Face Of Bulgari s India First-Ever, Exclusive Edition, Men s Kada Bracelet Costing ₹ 12 Lakh

Exclusive - Britain to back $1 billion World Bank green loan to India, sources say

British Prime Minister Boris Johnson is set to announce a sovereign guarantee for a $1 billion World Bank loan for India to develop green infrastructure, three sources familiar with the matter told Reuters on Monday.

Новини світу: коронавірусне пекло - що відбувається в Індії - Ексклюзив ТСН

Новини світу: коронавірусне пекло - що відбувається в Індії - Ексклюзив ТСН
tsn.ua - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tsn.ua Daily Mail and Mail on Sunday newspapers.

EXCLUSIVE-Ford puts projects with Mahindra on hold as it reassesses India strategy -sources

Ford, Mahindra had plans to build SUVs, share powertrains Ford renegotiating all projects with Mahindra - sources NEW DELHI/DETROIT, Feb 18 (Reuters) - Ford Motor has frozen all projects it was working on with Mahindra & Mahindra while it finalises a new India strategy, three people familiar with the U.S. carmaker’s plans told Reuters, weeks after the two companies called off their planned joint venture. “The options could include working out a new relationship with Mahindra or ending the relationship and related vehicles completely,” one of the sources said. The two other sources said they expect Ford to make a decision in about a month on whether to proceed with Mahindra in a different form or not, adding Ford Chief Executive Jim Farley wants to see a path to greater profitability in India.

EXCLUSIVE-India s Serum to sell AstraZeneca vaccine to Bangladesh at $4/dose - sources

Ruma Paul, Krishna N. Das 2 分钟阅读 DHAKA/NEW DELHI, Jan 11 (Reuters) - Serum Institute of India will sell the AstraZeneca coronavirus vaccine to Bangladesh at $4 a dose, three sources with knowledge of the mater told Reuters, about 47% more than India will pay for its inoculation campaign. The pricing for Bangladesh, the world’s eighth-most populous country, provides a first glimpse of what it will cost other low- and middle-income countries that are seeking to secure the vaccine developed by British drugmaker AstraZeneca with Oxford University. Bangladesh, a country of more than 160 million people, in November signed a preliminary agreement to buy 30 million doses of the shot from Serum - the world’s biggest vaccine maker by volume.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.